COMPOSITION PHARMACEUTIQUE CONTENANT UN DÉRIVÉ DE 1,2-DITHIOLTHIONE POUR LA PRÉVENTION OU LE TRAITEMENT D UNE MALADIE CAUSÉE PAR LA SUREXPRESSION DE LXR-ALPHA
Provided is a pharmaceutical composition that contains a 1,2-dithiolthionederivative, and is effective to prevent and treat a disease caused by overactivity of a liver X receptor&alpha； (LXR&alpha；) or a sterol response element binding protein (SREBP-1). Specifically, the pharmaceutical composition includes 1,2-dithiolthione derivatives such as 4-methyl-5-(2-pyrazinyl)-1,2-dithiol-3-thione, 3-methyl-1,2-dithiol-3-thione, or 5-(6-methoxypyrazinyl)-4-methyl-1,2-dithiol-3-thione. The pharmaceutical composition is effective for preventing and treating hypertension caused by renin, aldosteronism, adrenoleukodystrophy, glomerulosclerosis, proteinuria, nephropathy, liver steatosis, hypertriglyceridemia or hyperreninemia.
